Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Denton, C P; Avouac, J; Behrens, F; Furst, D E; Foeldvari, I; Humbert, M; Huscher, D; Kowal-Bielecka, O; Matucci-Cerinic, M; Nash, P; Opitz, C F; Pittrow, D; Rubin, L J; Seibold, J R; Distler, O (2011). Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed. Arthritis Research & Therapy, 13(3):114.

Ghofrani, H A; Distler, O; Gerhardt, F; Gorenflo, M; Grünig, E; Haefeli, W E; Held, M; Hoeper, M M; Kähler, C M; Kaemmerer, H; Klose, H; Köllner, V; Kopp, B; Mebus, S; Meyer, A; Miera, O; Pittrow, D; Riemekasten, G; Rosenkranz, S; Schranz, D; Voswinckel, R; Olschewski, H (2011). Treatment of pulmonary arterial hypertension (PAH): Updated Recommendations of the Cologne Consensus Conference 2011. International Journal of Cardiology, 154 (Suppl. 1):S20-S33.

Avouac, J; Kowal-Bielecka, O; Pittrow, D; et al; Distler, O (2010). Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group. Annals of the Rheumatic Diseases, 69(7):1360-1363.

Kowal-Bielecka, O; Avouac, J; Pittrow, D; Huscher, D; Behrens, F; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; Distler, O (2010). Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group. Journal of Rheumatology, 37(1):105-115.

Huscher, D; Pittrow, D; Distler, O; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Kowal-Bielecka, O; Avouac, J; Behrens, F; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Strand, V; Furst, D E; EPOSS-OMERACT Group (2010). Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Clinical and Experimental Rheumatology, 28(2 S 58):S47-52.

Ghofrani, H A; Distler, O; Gerhardt, F; Gorenflo, M; Grünig, E; Haefeli, W E; Held, M; Hoeper, M M; Kähler, C M; Kaemmerer, H; Klose, H; Köllner, V; Kopp, B; Mebus, S; Meyer, A; Miera, O; Pittrow, D; Riemekasten, G; Rosenkranz, S; Schranz, D; Voswinckel, R; Olschewski, H (2010). Therapie der pulmonal arteriellen Hypertonie (PAH). Empfehlungen der Kölner Konsensus-Konferenz 2010. Deutsche Medizinische Wochenschrift, 135(Supl 3):S87-S101.

Khanna, D; Distler, O; Avouac, J; Behrens, F; Clements, P J; Denton, C; Foeldvari, I; Giannini, E; Huscher, D; Kowal-Bielecka, O; Lovell, D; Matucci-Cerinic, M; Mayes, M; Merkel, P A; Nash, P; Opitz, C F; Pittrow, D; Rubin, L; Seibold, J R; Steen, V; Strand, C V; Tugwell, P S; Varga, J; Zink, A; Furst, D E (2009). Measures of response in clinical trials of systemic sclerosis: the combined response index for systemic sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS). Journal of Rheumatology, 36(10):2356-2361.

Distler, O; Behrens, F; Pittrow, D; Huscher, D; Denton, C P; Foeldvari, I; Humbert, M; Matucci-Cerinic, M; Nash, P; Opitz, C F; Rubin, L J; Seibold, J R; Furst, D E (2008). Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis and Rheumatism, 59(6):867-875.

This list was generated on Tue Oct 24 06:50:07 2017 CEST.